Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Recombination Dynamics in Thin-film Photovoltaic Materials via Time-resolved Microwave Conductivity.

Guse JA, Jones TW, Danos A, McCamey DR.

J Vis Exp. 2017 Mar 6;(121). doi: 10.3791/55232.

PMID:
28287568
2.

Spectral dependence of direct and trap-mediated recombination processes in lead halide perovskites using time resolved microwave conductivity.

Guse JA, Soufiani AM, Jiang L, Kim J, Cheng YB, Schmidt TW, Ho-Baillie A, McCamey DR.

Phys Chem Chem Phys. 2016 Apr 28;18(17):12043-9. doi: 10.1039/c5cp07360j.

PMID:
27067120
3.

Effects of Mentoring Speed Dating as an Innovative Matching Tool in Undergraduate Medical Education: A Mixed Methods Study.

Guse J, Schweigert E, Kulms G, Heinen I, Martens C, Guse AH.

PLoS One. 2016 Feb 9;11(2):e0147444. doi: 10.1371/journal.pone.0147444.

4.

The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness.

Dennis M, Sandercock P, Graham C, Forbes J; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration., Smith J.

Health Technol Assess. 2015 Sep;19(76):1-90. doi: 10.3310/hta19760.

5.

Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial.

CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration..

Lancet Neurol. 2014 Dec;13(12):1186-92. doi: 10.1016/S1474-4422(14)70258-3.

6.

Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial.

CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration., Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G.

Lancet. 2013 Aug 10;382(9891):516-24. doi: 10.1016/S0140-6736(13)61050-8. Erratum in: Lancet. 2013 Aug 10;382(9891):506. Lancet. 2013 Sep 21;382(9897):1020.

7.

Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis.

Mencarelli A, Distrutti E, Renga B, Cipriani S, Palladino G, Booth C, Tudor G, Guse JH, Hahn U, Burnet M, Fiorucci S.

Eur J Pharmacol. 2011 Aug 31;665(1-3):29-39. doi: 10.1016/j.ejphar.2011.04.036.

PMID:
21554873
8.

Getting ready for certification: pre-urodynamics evaluation.

Guse J.

Urol Nurs. 2009 Jul-Aug;29(4):267-8. No abstract available.

PMID:
19718944
9.

Getting ready for certification: urodynamics.

Guse JW.

Urol Nurs. 2009 Jan-Feb;29(1):55-6. No abstract available.

PMID:
19331278
10.

New sesquiterpene lactones with antibacterial activity from Vernonia fastigiata.

Roos G, Prawat H, Walter CU, Klaiber I, Vogler B, Guse JH, Kraus W.

Planta Med. 1998 Oct;64(7):673-4.

PMID:
17253310
11.

Bioassay guided isolation of a new C18-polyacetylene, (+)-9(Z),17-octadecadiene-12,14-diyne-1,11,16-triol, from Cassonia barteri.

Papajewski S, Guse JH, Klaiber I, Roos G, Süssmuth R, Vogler B, Walter CU, Kraus W.

Planta Med. 1998 Jun;64(5):479-81.

PMID:
17253268
12.

AWD-12-281 (inhaled) (elbion/GlaxoSmithKline).

Gutke HJ, Guse JH, Khobzaoui M, Renukappa-Gutke T, Burnet M.

Curr Opin Investig Drugs. 2005 Nov;6(11):1149-58. Review.

PMID:
16312137
13.

The radiological management of oesophageal food bolus obstruction using a gas-forming agent and barium.

Spinou E, Kubba H, Guse J, Johnston A.

Auris Nasus Larynx. 2003 Feb;30(1):103-5.

PMID:
12589861
14.

Vanillic acid 4-O-beta-D-(6'-O-galloyl) glucopyranoside and other constituents from the bark of Terminalia macroptera Guill.et Perr.

Conrad J, Vogler B, Klaiber I, Reeb S, Guse JH, Roos G, Kraus W.

Nat Prod Lett. 2001;15(1):35-42.

PMID:
11547421

Supplemental Content

Loading ...
Support Center